JPMorgan Names Yi Zhang Co‑Head of China Investment Banking

JPM-PM
March 18, 2026

JPMorgan Chase & Co. has appointed Yi Zhang, formerly the head of Goldman Sachs’ China investment banking team, to serve as co‑head of its China investment banking business alongside Michelle Wang. Zhang will join the firm in the summer of 2026 and will be responsible for overseeing corporate and investment banking operations across the country.

The move is part of a broader Asia‑Pacific strategy that has seen JPMorgan recruit senior talent from competitors, including the recent appointment of Yu Chikami as co‑head of investment banking in Japan and Jane Wu as head of China healthcare investment banking. In a related reshuffle, David Lau, the current co‑head of JPMorgan’s offshore China business, will transition to the role of vice chair of investment banking for the Asia‑Pacific region, allowing the bank to leverage his experience across a wider geographic scope.

Jiang’s appointment is designed to close the gap with rivals in China‑related deals, particularly in Hong Kong equity offerings where JPMorgan ranked seventh last year. The timing coincides with a revival in Hong Kong IPOs, with January 2026 becoming the busiest month on record, driven largely by Chinese technology firms in AI and advanced computing. By bringing in a leader with deep industrials and manufacturing coverage experience, JPMorgan aims to capture new deal flow and strengthen client relationships in a market that remains a key growth area for its global investment banking division.

JPMorgan’s long‑standing presence in China—highlighted by its 2020 full ownership of a futures company—provides a solid foundation for the expansion. The appointment reflects a broader trend of global banks intensifying their focus on Asia, with competitors such as Morgan Stanley and Citi also bolstering their teams to handle increasing deal activity.

The hiring of Yi Zhang represents a material executive change that can materially affect JPMorgan’s competitive positioning and future earnings potential in China, warranting publication as a high‑importance event.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.